Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...

Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...

Hyderabad: Amgen, a biotechnology major from the US, is making an investment of Rs 1,600 crore in Hyderabad by 2025-end. As ...

Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. | Revenues in the biopharma industry continued to boom ...

Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...

Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI ...

Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...